Gold prices tick higher on fresh U.S. tariff threats, Fed rate cut hopes
Carlos Nueno, President of International at Teladoc Health, Inc. (NYSE:TDOC), recently executed a notable transaction involving the company’s stock. The sale comes as Teladoc, currently valued at $1.6 billion, has seen its shares decline over 15% in the past week. On March 3, Nueno sold 2,347 shares of Teladoc Health common stock at an average price of $9.684 per share, totaling approximately $22,728. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value assessment.
In addition to this sale, Nueno engaged in several other transactions on February 28. These included the acquisition of 5,279 shares through the exercise of restricted and performance stock units. These transactions were executed at no cost per share, as the units convert to common stock on a one-for-one basis.
Following these transactions, Nueno’s direct ownership of Teladoc Health stock stands at 2,932 shares. The sale of shares was conducted to cover tax obligations related to the vesting of stock unit awards.
In other recent news, Teladoc Health Inc. reported its fourth-quarter 2024 earnings, revealing a revenue of $640.5 million, which slightly exceeded the forecast of $638.5 million. However, the company’s earnings per share (EPS) came in at -$0.28, missing the expected -$0.23. For the full year of 2024, Teladoc’s revenue was $2.6 billion, marking a 1% decrease from the previous year. The company ended the year with $1.3 billion in cash and cash equivalents. Analysts from Stifel and Needham maintained a Hold rating on Teladoc shares following these mixed results. Stifel noted that Teladoc’s guidance for 2025 fell below market consensus but aligned with their projections. Meanwhile, Needham highlighted uncertainties surrounding Teladoc’s future performance, citing challenges such as the loss of a large client and currency exchange headwinds. Teladoc’s BetterHelp division saw a sequential increase in average paying users during the fourth quarter, although the company continues to seek stabilization in this segment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.